• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2型与2019冠状病毒病:我们目前所了解的情况。

SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far.

作者信息

Rabi Firas A, Al Zoubi Mazhar S, Kasasbeh Ghena A, Salameh Dunia M, Al-Nasser Amjad D

机构信息

Department of Clinical Sciences, Faculty of Medicine, Yarmouk University, Irbid 21163, Jordan.

Department of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid 21163, Jordan.

出版信息

Pathogens. 2020 Mar 20;9(3):231. doi: 10.3390/pathogens9030231.

DOI:10.3390/pathogens9030231
PMID:32245083
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7157541/
Abstract

In December 2019, a cluster of fatal pneumonia cases presented in Wuhan, China. They were caused by a previously unknown coronavirus. All patients had been associated with the Wuhan Wholefood market, where seafood and live animals are sold. The virus spread rapidly and public health authorities in China initiated a containment effort. However, by that time, travelers had carried the virus to many countries, sparking memories of the previous coronavirus epidemics, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), and causing widespread media attention and panic. Based on clinical criteria and available serological and molecular information, the new disease was called coronavirus disease of 2019 (COVID-19), and the novel coronavirus was called SARS Coronavirus-2 (SARS-CoV-2), emphasizing its close relationship to the 2002 SARS virus (SARS-CoV). The scientific community raced to uncover the origin of the virus, understand the pathogenesis of the disease, develop treatment options, define the risk factors, and work on vaccine development. Here we present a summary of current knowledge regarding the novel coronavirus and the disease it causes.

摘要

2019年12月,中国武汉出现了一批致命肺炎病例。这些病例由一种此前未知的冠状病毒引起。所有患者都与武汉华南海鲜市场有关联,该市场售卖海鲜和活体动物。病毒迅速传播,中国公共卫生当局展开了防控工作。然而,彼时病毒已随旅行者传播至许多国家,引发了人们对之前冠状病毒疫情(严重急性呼吸综合征,即SARS,以及中东呼吸综合征,即MERS)的回忆,并引起了媒体的广泛关注和恐慌。根据临床标准以及现有的血清学和分子信息,这种新疾病被命名为2019冠状病毒病(COVID-19),这种新型冠状病毒被命名为严重急性呼吸综合征冠状病毒2(SARS-CoV-2),强调了它与2002年SARS病毒(SARS-CoV)的密切关系。科学界竞相揭示病毒的起源,了解疾病的发病机制,开发治疗方案,确定风险因素,并致力于疫苗研发。在此,我们对有关新型冠状病毒及其所致疾病的现有知识做一总结。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49f3/7157541/ac4e67488c5c/pathogens-09-00231-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49f3/7157541/be47d9bbbf3c/pathogens-09-00231-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49f3/7157541/d582ce5d385d/pathogens-09-00231-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49f3/7157541/3a318eada616/pathogens-09-00231-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49f3/7157541/ac4e67488c5c/pathogens-09-00231-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49f3/7157541/be47d9bbbf3c/pathogens-09-00231-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49f3/7157541/d582ce5d385d/pathogens-09-00231-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49f3/7157541/3a318eada616/pathogens-09-00231-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49f3/7157541/ac4e67488c5c/pathogens-09-00231-g004.jpg

相似文献

1
SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far.严重急性呼吸综合征冠状病毒2型与2019冠状病毒病:我们目前所了解的情况。
Pathogens. 2020 Mar 20;9(3):231. doi: 10.3390/pathogens9030231.
2
COVID-19 in Human, Animal, and Environment: A Review.人类、动物和环境中的新冠病毒:综述
Front Vet Sci. 2020 Sep 4;7:578. doi: 10.3389/fvets.2020.00578. eCollection 2020.
3
Clinical Spectrum of COVID-19 Cases and their Correlation with S.LDH Levels- An Observational Study from Southeast Rajasthan.COVID-19 病例的临床谱及其与 S.LDH 水平的相关性-来自拉贾斯坦邦东南部的观察性研究。
J Assoc Physicians India. 2021 Sep;69(9):11-12.
4
Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19).严重急性呼吸综合征冠状病毒2(SARS-CoV-2;冠状病毒病-19)的流行病学、病毒学及临床特征
Clin Exp Pediatr. 2020 Apr;63(4):119-124. doi: 10.3345/cep.2020.00493. Epub 2020 Apr 2.
5
Comprehensive overview of COVID-19 based on current evidence.基于现有证据的 COVID-19 综合概述。
Dermatol Ther. 2020 Sep;33(5):e13525. doi: 10.1111/dth.13525. Epub 2020 May 22.
6
The novel zoonotic COVID-19 pandemic: An expected global health concern.新型人畜共患的新冠疫情:一个意料之中的全球卫生问题。
J Infect Dev Ctries. 2020 Mar 31;14(3):254-264. doi: 10.3855/jidc.12671.
7
Overview: The history and pediatric perspectives of severe acute respiratory syndromes: Novel or just like SARS.概述:严重急性呼吸系统综合征的历史和儿科视角:新型还是类似 SARS。
Pediatr Pulmonol. 2020 Jul;55(7):1584-1591. doi: 10.1002/ppul.24810. Epub 2020 Jun 1.
8
Coronavirus diseases and pregnancy: COVID-19,SARS, and MERS.冠状病毒疾病与妊娠:新型冠状病毒肺炎、严重急性呼吸综合征和中东呼吸综合征
Przegl Epidemiol. 2020;74(2):276-289. doi: 10.32394/pe.74.21.
9
Coronaviruses: severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus in travelers.冠状病毒:旅行者中的严重急性呼吸综合征冠状病毒和中东呼吸综合征冠状病毒
Curr Opin Infect Dis. 2014 Oct;27(5):411-7. doi: 10.1097/QCO.0000000000000089.
10
Current therapeutic options for coronavirus disease 2019 (COVID-19)-lessons learned from severe acute respiratory syndrome (SARS) and Middle East Respiratory Syndrome (MERS) therapy: a systematic review protocol.2019冠状病毒病(COVID-19)的当前治疗选择——从严重急性呼吸综合征(SARS)和中东呼吸综合征(MERS)治疗中吸取的经验教训:一项系统评价方案
Ann Transl Med. 2020 Nov;8(22):1527. doi: 10.21037/atm-20-2340.

引用本文的文献

1
Neuro-Ophthalmic Manifestation Associated With COVID-19 in a Tertiary Eye Center in Nepal.尼泊尔一家三级眼科中心与新冠病毒病相关的神经眼科表现
Case Rep Ophthalmol Med. 2025 Jul 26;2025:6694537. doi: 10.1155/crop/6694537. eCollection 2025.
2
Coronavirus in Recent Years: Characteristics, Outbreaks, and Treatments.近年来的冠状病毒:特征、疫情及治疗方法
Tanaffos. 2024 Mar;23(3):220-237.
3
What Lessons can Be Learned From the Management of the COVID-19 Pandemic?从新冠疫情管理中可以吸取哪些教训?

本文引用的文献

1
The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020.2019新型冠状病毒病(COVID-19)疫情的流行病学特征 - 中国,2020年
China CDC Wkly. 2020 Feb 21;2(8):113-122.
2
A Novel Coronavirus Genome Identified in a Cluster of Pneumonia Cases - Wuhan, China 2019-2020.在中国武汉2019 - 2020年肺炎病例群中发现的一种新型冠状病毒基因组
China CDC Wkly. 2020 Jan 24;2(4):61-62.
3
Did pangolins spread the China coronavirus to people?穿山甲将新冠病毒传播给人类了吗?
Int J Public Health. 2025 May 30;70:1607727. doi: 10.3389/ijph.2025.1607727. eCollection 2025.
4
Potential blocker of SARS-CoV entry and a narrow functionality of its spike protein motifs on Qubevirus platform.严重急性呼吸综合征冠状病毒(SARS-CoV)进入的潜在阻断剂及其刺突蛋白基序在库贝病毒平台上的狭窄功能。
J Biol Chem. 2025 Jun 12;301(7):110371. doi: 10.1016/j.jbc.2025.110371.
5
Deep viewing for the identification of Covid-19 infection status from chest X-Ray image using CNN based architecture.基于卷积神经网络架构,通过深度观察从胸部X光图像识别新冠病毒感染状态。
Intell Syst Appl. 2022 Nov;16:200130. doi: 10.1016/j.iswa.2022.200130. Epub 2022 Oct 6.
6
Comparative Examination of Feline Coronavirus and Canine Coronavirus Effects on Extracellular Vesicles Acquired from A-72 Canine Fibrosarcoma Cell Line.猫冠状病毒和犬冠状病毒对源自A-72犬纤维肉瘤细胞系的细胞外囊泡影响的比较研究
Vet Sci. 2025 May 15;12(5):477. doi: 10.3390/vetsci12050477.
7
Nuclear shuttling of CDC4 mediated broad-spectrum antiviral activity against diverse coronaviruses.CDC4的核穿梭介导了针对多种冠状病毒的广谱抗病毒活性。
Emerg Microbes Infect. 2025 Dec;14(1):2493922. doi: 10.1080/22221751.2025.2493922. Epub 2025 May 6.
8
Animal Models for Human-Pathogenic Coronavirus and Animal Coronavirus Research.用于人类致病性冠状病毒和动物冠状病毒研究的动物模型
Viruses. 2025 Jan 14;17(1):100. doi: 10.3390/v17010100.
9
Gene expression profiles of precursor cells identify compounds that reduce NRP1 surface expression in macrophages: Implication for drug repositioning for COVID-19.前体细胞的基因表达谱可鉴定出降低巨噬细胞中神经纤毛蛋白1(NRP1)表面表达的化合物:对COVID-19药物重新定位的启示。
Front Cardiovasc Med. 2024 Oct 24;11:1438396. doi: 10.3389/fcvm.2024.1438396. eCollection 2024.
10
Multipotent mesenchymal stromal/stem cell-based therapies for acute respiratory distress syndrome: current progress, challenges, and future frontiers.基于多能间充质基质/干细胞的急性呼吸窘迫综合征治疗:当前进展、挑战和未来前沿。
Braz J Med Biol Res. 2024 Oct 14;57:e13219. doi: 10.1590/1414-431X2024e13219. eCollection 2024.
Nature. 2020 Feb 7. doi: 10.1038/d41586-020-00364-2.
4
Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2.新型冠状病毒(SARS-CoV-2)受体ACE2的单细胞RNA表达谱分析
Am J Respir Crit Care Med. 2020 Sep 1;202(5):756-759. doi: 10.1164/rccm.202001-0179LE.
5
The proximal origin of SARS-CoV-2.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的近端起源。
Nat Med. 2020 Apr;26(4):450-452. doi: 10.1038/s41591-020-0820-9.
6
Presumed Asymptomatic Carrier Transmission of COVID-19.新冠病毒无症状感染者的传播。
JAMA. 2020 Apr 14;323(14):1406-1407. doi: 10.1001/jama.2020.2565.
7
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.2019 年新型冠状病毒刺突蛋白在预融合构象的冷冻电镜结构
Science. 2020 Mar 13;367(6483):1260-1263. doi: 10.1126/science.abb2507. Epub 2020 Feb 19.
8
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients.感染患者上呼吸道标本中的新型冠状病毒2型病毒载量
N Engl J Med. 2020 Mar 19;382(12):1177-1179. doi: 10.1056/NEJMc2001737. Epub 2020 Feb 19.
9
Defining the Epidemiology of Covid-19 - Studies Needed.定义新冠病毒病的流行病学——所需的研究。
N Engl J Med. 2020 Mar 26;382(13):1194-1196. doi: 10.1056/NEJMp2002125. Epub 2020 Feb 19.
10
More than 80 clinical trials launch to test coronavirus treatments.80多项临床试验启动以测试新冠病毒治疗方法。
Nature. 2020 Feb;578(7795):347-348. doi: 10.1038/d41586-020-00444-3.